Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ampelopsin
1. Ampelopsin
2. 27200-12-0
3. Ampeloptin
4. (+)-dihydromyricetin
5. (+)-ampelopsin
6. (2r,3r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-4-one
7. Telocapil
8. Myriceline Spe
9. Flavanone, 3,3',4',5,5',7-hexahydroxy-
10. 4h-1-benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2r-trans)-
11. (2r,3r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-4-one
12. Kd8qnd6427
13. Chebi:28429
14. 4h-1-benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2r,3r)-
15. (2r,3r)-2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4h-1-benzopyran-4-one
16. (2r,3r)-3,5,7,3',4',5'-hexahydroxyflavanone
17. Ampelopsin (flavanol)
18. (2r,3r)-3,3',4',5,5',7-hexahydroxy-2,3-dihydroflavanonol
19. Dihydro-myricetin
20. (2r,3r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydro-4h-chromen-4-one
21. Unii-kd8qnd6427
22. 3,3',4',5,5',7-hexahydroxy-2,3-dihydroflavanonol
23. Ampelopsin [mi]
24. (2r,3r)-dihydromyricetin
25. Dihydromyricetin (dih-myr)
26. (2r-trans)-2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4h-1-benzopyran-4-one
27. Dihydromyricetin (ampeloptin)
28. Dihydromyricetin - Ampeloptin
29. Schembl723736
30. Dihydromyricetin [inci]
31. Chembl3348861
32. Dtxsid50181676
33. Bdbm212434
34. Hms3884b17
35. Dihydromyricetin, >=98% (hplc)
36. Hy-n0112
37. Dihydromyricetin, Analytical Standard
38. Mfcd00189451
39. S2399
40. Akos022168215
41. Zinc100037633
42. Ac-8004
43. Ccg-267699
44. Cs-3809
45. Ncgc00346604-01
46. As-71702
47. D5464
48. Sw219328-1
49. C02906
50. A818952
51. Q422305
52. 2b89fbac-4dd1-44c9-be2a-9d0c173bdfd8
53. Q-100341
54. (2r,3r)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-one
| Molecular Weight | 320.25 g/mol |
|---|---|
| Molecular Formula | C15H12O8 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 1 |
| Exact Mass | 320.05321734 g/mol |
| Monoisotopic Mass | 320.05321734 g/mol |
| Topological Polar Surface Area | 148 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 445 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Dihydromyricetin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydromyricetin, including repackagers and relabelers. The FDA regulates Dihydromyricetin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydromyricetin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dihydromyricetin supplier is an individual or a company that provides Dihydromyricetin active pharmaceutical ingredient (API) or Dihydromyricetin finished formulations upon request. The Dihydromyricetin suppliers may include Dihydromyricetin API manufacturers, exporters, distributors and traders.
Dihydromyricetin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydromyricetin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydromyricetin GMP manufacturer or Dihydromyricetin GMP API supplier for your needs.
A Dihydromyricetin CoA (Certificate of Analysis) is a formal document that attests to Dihydromyricetin's compliance with Dihydromyricetin specifications and serves as a tool for batch-level quality control.
Dihydromyricetin CoA mostly includes findings from lab analyses of a specific batch. For each Dihydromyricetin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydromyricetin may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydromyricetin EP), Dihydromyricetin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydromyricetin USP).
LOOKING FOR A SUPPLIER?
